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Meningitis is associated with high mortality and long-term complications among survivors
in the neonatal period.1–3 Adequate treatment relies on proper diagnosis, and only
cerebrospinal fluid (CSF) culture can definitively diagnose meningitis.1,4–8 When evaluating
an infant for sepsis, many clinicians choose to obtain a blood culture and await a positive
result before performing a lumbar puncture. This strategy underestimates the incidence of
meningitis; furthermore, up to 50% of very low birth weight (<1500 g) infants with
meningitis have a negative blood culture.8
The concordance between blood, urine, and CSF cultures may affect management strategies
for sepsis and meningitis. Meningitis in the neonate is classified as early- or late-onset
depending on the time after birth when it occurs. The majority (61.4%) of late-onset sepsis
cases are caused by Gram-positive organisms.9 Prior studies have found 39% of blood and
CSF cultures to be concordant with Gram-positive organisms compared with 16% of blood
and urine cultures.10,11 However, the relationship between individual organisms present in
blood and CSF cultures, as well as between concordance and the timing of blood and CSF
cultures, have not been fully described. We sought to determine the concordance of
organisms between blood and CSF cultures and to evaluate predictors of concordance
adjusting for markers of severity of illness.
METHODS
We identified all infants discharged from 333 neonatal intensive care units (NICUs)
managed by the Pediatrix Medical Group from 1997–2010 with at least one positive blood
culture paired with a CSF culture in the first 120 postnatal days of life. The Pediatrix
Medical Group maintains an administrative database that prospectively captures information
from notes generated by clinicians on all infants cared for by the group. Data on multiple
aspects of care are entered into the system to generate admission notes, daily progress notes,
procedure notes, and discharge summaries. Information is collected regarding maternal
history and demographics, medications, laboratory results, culture results, and diagnoses.
We defined a blood-CSF culture pair obtained in the same infant by the following rules: (1)
We excluded blood cultures positive for organisms considered contaminants, including non-
speciated streptococci, Bacillus sp., Corynebacterium sp., diphtheroids sp., Gram-positive
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rods (not including Listeria sp.), Lactobacillus sp., Micrococcus sp., Stomatococcus sp., and
Bacteroides sp. (2) When multiple positive blood cultures with the same organism were
obtained within a 21-day period, they were considered to be a common infectious episode,
and only the first positive culture was retained for analysis. (3) Multiple CSF cultures within
the same 21-day period were also considered to be a common infectious episode, and only
the first positive culture was retained for analysis. (4) Blood and CSF cultures positive with
>1 organism were treated as separate positive cultures. If one of the organisms was
considered a contaminant, we counted only the true organism as a positive culture and
ignored the contaminant.
We included positive blood cultures in the analysis if they could be paired with a CSF
culture obtained in the same infant on the same day as the blood culture or up to three days
before or three days after the positive blood culture. If multiple blood cultures could be
paired with the same CSF culture, they were each counted as separate blood-CSF culture
pair. If multiple CSF cultures could be paired with the same blood culture, we kept, in order
of preference, a positive CSF culture over a negative CSF culture, a CSF culture obtained on
the same day over a CSF culture obtained before or after the blood culture, and then a CSF
culture obtained closest in time before or after the blood culture. All blood cultures that
could not be paired with a CSF culture and all CSF cultures that could not be paired with a
blood culture were excluded from the analysis.
We defined blood-CSF culture concordance as the growth of the same organism in the blood
and CSF of the blood-CSF culture pair. We defined blood-CSF culture discordance as either
the growth of an organism in the blood culture but not the CSF culture, or the growth of two
different organisms in each one of the two cultures of each pair. We also examined group B
streptococcal (GBS) concordance in early- and late-onset GBS sepsis. We determined
concordance for early-onset (<3 days of life) as well as late-onset (≥3 days of life) GBS
sepsis in infants with a GBS-positive blood culture.
Statistical Analysis
The unit of observation for this study was a blood-CSF culture pair. We used standard
summary statistics to describe the study variables. We compared infant-level and culture-
level characteristics, including organism genus and group (Gram-positive, Gram-negative,
or fungal organisms) between the categories of concordant versus discordant blood-CSF
culture pairs using chi-square tests of association and Wilcoxon rank sum tests where
appropriate. We used univariable and multivariable logistic regression analysis to evaluate
the odds of a concordant versus discordant blood-CSF culture pair, controlling for the
organism grown in the blood culture, gestational age (GA) in weeks, postnatal age in days,
fraction of inspired oxygen (FiO2) <30% or ≥30% on the day of the blood culture,
mechanical ventilation on the day of the blood culture, use of inotropes (dopamine,
dobutamine, epinephrine, norepinephrine, phenylephrine, or vasopressin) on the day of the
blood culture, the day of CSF culture with respect to the blood culture, the presence of a
ventriculo-peritoneal (VP) shunt, and exposure to CSF-penetrating antibiotics (cefepime,
cefotaxime, ceftriaxone, ceftazidime, meropenem, imipenem/cilastatin) before the day of the
CSF culture. We did not include ampicillin as a CSF-penetrating antibiotic in our cohort due
to absence of dosing information and the required high dose for CSF penetration. We used
the method of generalizing estimating equations with an exchangeable (compound
symmetry) covariance structure to account for correlation between multiple blood-CSF
culture pairs obtained in the same infant. We repeated these analyses separately in infants
who grew only Gram-negative and Gram-positive organisms from their blood culture.
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We used Stata 12 (College Station, TX), and statistical significance was defined as a p<0.05.
The study was approved by the Duke University Institutional Review Board without the
need for written informed consent because the data were collected without identifiers.
RESULTS
Infant characteristics
We identified 8839 infants with at least one positive blood culture that could be paired with
a CSF culture (Table 1); 220 infants (3%) had a VP shunt. The median GA was 30 weeks
(5th and 95th percentile; 24, 40), and the median birth weight was 1407 g (600, 3762). The
median day of life of first positive blood culture for each infant was 12 (0, 66).
Blood-CSF culture pairs
There were 9408 positive blood cultures paired with a CSF culture, and 440 (5%) were
concordant (Figure 1). Of the 8968 discordant cultures, 73 (<1%) were due to growth of two
different organisms in the blood and CSF, and the remaining 8895 (99%) discordant pairs
were a result of a positive blood culture and a negative CSF culture. Of the 440 concordant
pairs, 232 (53%) were Gram-positive, 168 (38%) were Gram-negative, and 40 (< 1%) were
attributable to fungi or other organisms. Of the 5540 Gram-positive blood-CSF culture pairs,
the most commonly cultured organisms in the blood were GBS (1950, 35%), coagulase-
negative staphylococci (CoNS) (1265, 23%), and S. aureus (1169, 21%). Of the 3151 Gram-
negative blood-CSF culture pairs, the most commonly cultured organisms from the blood
were E. coli (1297, 41%) and Klebsiella (634, 20%). The most commonly concordant
organisms of the 440 concordant pairs were GBS (145, 33%), E. coli (84, 19%), S. aureus
(49, 11%), and C. albicans (28, 6%).
We found that the most frequently cultured organisms in the blood were not the most
commonly concordant organisms (Table 2). CoNS represented 1265/9408 (13%) of the total
blood-CSF culture pair population, but only 4/1265 (<1%) of the paired CSF cultures were
positive for CoNS. Serratia represented 227/9408 (2%) of the total blood-CSF culture pair
population, and 24/227 (11%) of the paired blood-CSF cultures were positive for Serratia.
Streptococcus pnemoniae grew in 64/9408 (< 1%) of blood cultures, and 7/64 (11%) of the
paired blood and CSF cultures were positive for S. pneumoniae.
The majority of blood-CSF culture pairs (3234/9408, 34%) were paired on the first day
following the blood culture, with 141 (4%) concordant (Figure 2). When blood and CSF
cultures were obtained on the same day, the percentage of concordance was higher
(228/2138, 11%) than when the CSF was obtained before (7/311, 2%) or after (205/6959,
3%) the blood culture (Figure 2). For GBS-positive blood culture obtained in the first three
days of life (1403), 52 (4%) of the blood and CSF cultures were concordant. For GBS-
positive blood culture obtained after the first three days of life (547), 93 (17%) of the blood
and CSF cultures were concordant (p <0.001).
Comparison of culture pairs in infants with and without a VP shunt
Of the 9150 blood-CSF culture pairs from infants without a VP shunt, only 396 (4%) were
concordant (Table 2). The most frequently cultured organisms from the blood were GBS
(1940, 21%), E. coli (1273, 14%), CoNS (1217, 13%), and S. aureus (1133, 12%). The most
commonly concordant organisms between the blood and CSF in which there were at least 10
positive blood cultures were Salmonella (5/23, 22%), S. pneumo (7/64, 11%), Serratia
(20/209, 10%), and Listeria (4/49, 8%).
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Of the 258 blood-CSF culture pairs from infants with a VP shunt, 44 (17%) were
concordant. The most frequently cultured organisms from the blood in the infants with a VP
shunt were CoNS (48/258, 19%) and S. aureus (36/258, 14%). Organisms with at least 10
positive blood cultures with the highest concordance included E. coli (12/24, 50%), Serratia
(4/18, 22%), Enterobacter (3/14, 21%), and S. aureus (6/36, 17%) (Table 2).
Logistic regression
On multivariable analysis, infants with a VP shunt had an increased odds of concordance
compared to infants without a VP shunt (Table 3). When CSF cultures were obtained on the
same day as the blood culture, the odds of concordance was higher than when CSF cultures
were obtained before or after the blood cultures.
We also observed higher concordance in infants exposed to CSF-penetrating antibiotics the
day before drawing the CSF culture (OR=2.18 [95% confidence interval; 1.65–2.89]). Of the
1240 CSF cultures obtained following infant exposure to these antibiotics, 85 (7%) were
concordant in the blood and CSF compared to only 355/8168 (4%) concordant blood-CSF
cultures from infants who were not exposed to CSF-penetrating antibiotics prior to obtaining
the CSF culture. The most common organisms found concordant from blood-CSF culture
pairs in which the CSF culture was obtained after administration of a CSF-penetrating
antibiotic were GBS (20/109, 18%), Citrobacter (2/16, 13%), E. coli (26/250, 10%), C.
albicans (9/94, 10%), and Pseudomonas (3/29, 10%). Among infants with Gram-negative
organisms isolated in the blood, infants with a VP shunt were more likely to have
concordant CSF cultures (OR=7.60 [4.26 – 13.58]) compared to infants without a VP shunt.
Among infants with Gram-positive organisms isolated in the blood, infants with a VP shunt
were more likely to have concordant CSF cultures (OR=3.17 [1.65 – 6.11]) compared to
infants without a VP shunt.
DISCUSSION
In this large cohort of infants, we observed that blood-CSF culture concordance was
associated with the presence of Gram-negative and fungal organisms, presence of a VP
shunt, and timing of the CSF culture on the same day as the blood culture. We also observed
increased concordance in cultures from infants exposed to CSF-penetrating antibiotics prior
to blood-CSF culture pairing. Gram-positive organisms were cultured more frequently in our
cohort than any other organism, which is consistent with previous studies.12,13 The overall
incidence of culture-positive meningitis, as well as the distribution of organisms in this
cohort, was similar to previously reported cohorts of hospitalized infants.13–15
Infants with blood-CSF concordance were more likely to have indicators related to increased
severity of illness, such as mechanical ventilation, inotropic drug use, and presence of a VP
shunt. Overall, there was a four-fold increase in blood-CSF culture concordance in infants
with a VP shunt, regardless of the organism type. The increase in all-organism concordance
and Gram-negative concordance in infants with VP shunts is likely due to placement of the
VP shunt in the peritoneal cavity.16,17 Because meningitis in the infant is often due to the
spread of pathogens from the blood into the CSF, and organisms frequently associated with
peritoneal infection are Gram-negative rods including E. coli, it is possible that these
pathogens can cause meningitis in several ways: They may spread from a local peritoneal
infection to the blood and continue to spread to the ventricles, or they may spread from the
peritoneum into the ventricles of the brain through the shunt, leading to meningitis.16,18–20
Alternatively, it is possible that infection starts within the shunt itself and spreads to the
blood stream, causing sepsis due to structural abnormalities in the shunts.17
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Serratia had one of the highest incidences of concordance between the blood and CSF in our
data, both in infants with (22%) and without (10%) a VP shunt. Serratia bloodstream
infections have been associated with morbidities including brain abscesses, which are
difficult to treat even with appropriate CSF-penetrating antibiotics, and development of
ventriculitis and parenchymal necrosis.21
The clinical presentation for meningitis in infants is non-specific. It may present as a
multitude of symptoms, including feeding difficulties, temperature instability, respiratory
distress, as well as vomiting, diarrhea, and seizures, making it difficult to separate from the
clinical presentation of other etiologies (e.g., apnea of prematurity, urinary tract infection,
necrotizing enterocolitis). Although CSF culture is the gold standard for diagnosis of
meningitis, the optimal time for a lumbar puncture in infants with clinical signs and
symptoms of sepsis and meningitis is uncertain.6,8,22,23 We found that approximately one
out of 20 positive blood cultures grew the same organism in the CSF culture.
In our study, the cases of meningitis may be underestimated because nearly 75% of the
blood-CSF culture pairs were matched in the three days following the positive blood culture.
The most likely explanation is that a positive blood culture prompted a lumbar puncture to
rule out meningitis. Given that most clinicians choose to administer antibiotics while waiting
for blood culture results, this delay in matching may have resulted in sterilization of the CSF
and thus negative CSF cultures. We found that the proportion of concordant CSF and blood
cultures was four times higher when the blood and CSF cultures were obtained on the same
day compared with when the CSF was obtained before or after the blood culture. This
demonstrates the importance of obtaining the CSF at the time of the sepsis evaluation to
most accurately diagnose and treat potential meningitis in an infant. CSF should continue to
be collected at the time of sepsis evaluation for diagnosis of meningitis confirmation and
guidance of correct treatment, if the infant is able to withstand the procedure.
When we examined whether the infants were exposed to CSF-penetrating antibiotics
(cefepime, cefotaxime, ceftriaxone, ceftazidime, meropenem, imipenem/cilistatin) the day
before a CSF culture was drawn, the odds of concordance increased in the exposed infants.
Potential reasons for this phenomenon include lower CSF penetration of these drugs than
expected or a delay in reaching steady-state levels in the CSF (potentially longer than one
day). Physicians may administer these antibiotics because of a high degree of suspicion that
infants with a positive blood culture could have meningitis based on clinical signs and
symptoms (e.g., seizure, vital sign instability, or other central nervous system symptoms).
Therefore, it is possible that a clinician’s choice to initiate empirical antibiotics was meant to
treat meningitis. However, if the antibiotics take a longer time to reach a steady state in the
CSF, the meningitis would not be treated within the first day, and the culture would be
positive once obtained. The symptoms an infant exhibited may also have been consistent
with a diagnosis of meningitis, thus encouraging a physician to administer antibiotics earlier,
before a lumbar puncture and CSF culture were obtained.
There were a few limitations to this study. Given the multicenter, retrospective design, there
was not a systematic approach to evaluation of sepsis. The study was also limited by the lack
of antibiotic sensitivities for each organism and lack of information regarding medication
dosing. As an example, ampicillin was not classified as a CSF-penetrating antibiotic
although concentrations were likely high enough to treat GBS but not Gram-negative rods.
Study strengths included the large sample size and ability to examine organism-level
characteristics across blood-CSF culture pairs. This cohort includes data on infants from 333
NICUs across North America, including both academic and community sites, allowing these
results to be generalizable to many institutions as well as a wide range of NICU populations.
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In this study, we found that the presence of a VP shunt, increased severity of illness, and
obtaining blood and CSF cultures on the same day were all related to an increase in the
possibility of a concordant blood-CSF culture pair. This concordance also varied depending
on the specific organism. Overall, obtaining a lumbar puncture in a timely manner in these
infants is essential. If more lumbar punctures are obtained on the same day and even at the
same time as the blood culture, it is possible that more infants might be diagnosed with
meningitis and treated accordingly. Due to wide variability in NICU site performance of
lumbar punctures in infants with suspected meningitis, determining a clear relationship
between blood culture and CSF culture concordance will potentially aid in correct diagnosis
and treatment of neonatal meningitis, particularly in infants with VP shunts.
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TABLE 1
Demographics
Infants with blood-CSF culture concordance
N=437
n (%)




 ≤25 81 (19) 1359 (16)
 26–32 182 (42) 3675 (44)
 33–36 49 (11) 1099 (13)
 ≥37 122 (28) 2235 (27)
Birth weight, g
 <1000 134 (31) 2695 (32)
 1000–1499 88 (20) 1765 (21)
 1500–2499 79 (18) 1414 (17)
 2500–3499 98 (22) 1656 (20)
 ≥3500 34 (8) 836 (10)
Sex
 Male 236 (54) 4631 (55)
Race/ethnicity
 White 205 (47) 3887 (46)
 Black 100 (23) 1962 (24)
 Hispanic 101 (23) 1836 (22)
 Other 16 (4) 387 (5)
VP shunt
 Yes 44 (10) 176 (2)
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TABLE 2
Blood-CSF Culture Concordance
No VP shunt, N = 8619
Concordant blood-CSF pairs (%)
VP shunt, N = 220
Concordant blood-CSF pairs
(%)
Total, N = 8839
Concordant blood-CSF pairs
(%)
Gram-negative organisms 142/3055 (5) 26/96 (27) 168/3151 (5)
 Acinetobacter 0/43 (0) 0/1 (0) 0/44 (0)
 Citrobacter 2/56 (4) 0/3 (0) 2/59 (3)
 Escherichia coli 72/1273 (6) 12/24 (50) 84/1297 (6)
 Enterobacter 13/376 (3) 3/14 (21) 16/390 (4)
 Hemophilus influenza 2/125 (2) 0/2 (0) 2/127 (2)
 Klebsiella 17/612 (3) 1/22 (5) 18/634 (3)
 Proteus 1/22 (5) 0/0 (0) 1/22 (5)
 Pseudomonas 4/130 (3) 4/6 (67) 8/136 (6)
 Salmonella 5/23 (22) 0/0 (0) 5/23 (22)
 Serratia marcescens 20/209 (10) 4/18 (22) 24/227 (11)
 Other 6/186 (3) 2/6 (33) 8/192 (4)
Gram-positive organisms 216/5412 (4) 16/128 (13) 232/5540 (4)
 CoNS 2/1217 (<1) 2/48 (4) 4/1265 (<1)
 Enterococcus 10/521 (2) 3/23 (13) 13/544 (2)
 Group B Streptococcus 140/1940 (7) 5/10 (50) 145/1950 (7)
 Listeria 4/49 (8) 0/1 (0) 4/50 (8)
 Staphylococcus aureus 43/1133 (4) 6/36 (17) 49/1169 (4)
 Streptococcus pneumoniae 7/64 (11) 0/0 (0) 7/64 (11)
 Other 10/488 (2) 0/10 (0) 10/498 (2)
Fungus 26/472 (6) 2/23 (9) 28/495 (6)
 Candida 26/469 (6) 2/23 (9) 28/492 (6)
 Malassezia 0/3 (0) 0/0 (0) 0/3 (0)
Other 12/211 (6) 0/11 (0) 12/222 (5)
Total 396/9150 (4) 44/258 (17) 440/9408 (5)
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TABLE 3
Adjusted Odds Ratios for Concordance of CSF Cultures with Blood Cultures
Multivariable Regression
Odds Ratio P
Organism type in blood-CSF pair
 Gram-positive cocci 1.00 (reference)
 Gram-negative rods 1.27 (1.02–1.61) 0.04
 Fungus 1.27 (0.82–1.96) 0.29
 Other 1.34 (0.66–2.72) 0.41
Gestational age (weeks)
 <25 1.00 (reference)
 26–28 0.94 (0.68–1.32) 0.75
 29–32 1.23 (0.86–1.78) 0.26
 33–36 1.24 (0.79–1.94) 0.34
 ≥37 1.71 (1.12–2.62) 0.01
Day of life of blood culture
 0–3 days 1.00 (reference)
 4–28 days 1.23 (0.90–1.68) 0.19
 ≥28 days 0.94 (0.64–1.37) 0.73
Exposure to CSF penetrating antibiotic before blood-CSF culture pairing
 Yes 2.18 (1.65–2.89) <0.01
CSF culture day with respect to blood culture
 Before 1.00 (reference)
 Same day 6.11 (2.81–13.24) <0.01
 After 1.48 (0.68–3.22) 0.32
Mechanical ventilation on day of blood culture
 Yes 1.51 (1.15–1.97) <0.01
FiO2 on day of blood culture
 ≥30% 1.11 (0.88–1.41) 0.39
Inotropes on day of blood culture
 Yes 1.84 (1.26–2.67) <0.01
VP shunt
 Yes 3.87 (2.59–5.78) <0.01
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